[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

AR002981A1 - Un envase que aloja una composicion farmaceutica que comprende una solucion acuosa de clorhidrato de procaterol, y una composicion farmaceutica quecomprende una solucion acuosa de clorhidrato de procaterol - Google Patents

Un envase que aloja una composicion farmaceutica que comprende una solucion acuosa de clorhidrato de procaterol, y una composicion farmaceutica quecomprende una solucion acuosa de clorhidrato de procaterol

Info

Publication number
AR002981A1
AR002981A1 ARP960102037A AR10203796A AR002981A1 AR 002981 A1 AR002981 A1 AR 002981A1 AR P960102037 A ARP960102037 A AR P960102037A AR 10203796 A AR10203796 A AR 10203796A AR 002981 A1 AR002981 A1 AR 002981A1
Authority
AR
Argentina
Prior art keywords
pharmaceutical composition
procaterol
aqueous solution
chlorhydrate
procaterol hydrochloride
Prior art date
Application number
ARP960102037A
Other languages
English (en)
Inventor
Yuzo Kimura
Shinichi Ishikawa
Masafumi Toda
Takakuni Matsuda
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Publication of AR002981A1 publication Critical patent/AR002981A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4704—2-Quinolinones, e.g. carbostyril

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)

Abstract

La presente invención se refiere a un envase que aloja una composición farmacéutica que comprende una solución acuosa de clorhidrato de procaterol detal modo que el clorhidrato de procaterol no se descompone en la solución debido a su reacción de oxidación. Además se refiere a una composiciónfarmacéutica que comprende una solución acuosa de clorhidrato de procaterol que contiene un compuesto de alto peso molecular, soluble en agua, que contieneun grupo funcional aniónico y tiene un peso molecular de por lo menos 10.000. El envase que aloja la formulación de solución acuosa de clorhidrato deprocaterol de acuerdo con la invención aumenta la estabilidad de almacenamiento a largo plazo de la formulación. Además la formulación de solución acuosa declorhidrato de procaterol que contiene el compuesto de alto peso molecular soluble en agua específico anterior puede producir efectos marcadamenteprolongados.
ARP960102037A 1995-04-04 1996-04-03 Un envase que aloja una composicion farmaceutica que comprende una solucion acuosa de clorhidrato de procaterol, y una composicion farmaceutica quecomprende una solucion acuosa de clorhidrato de procaterol AR002981A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP7856495 1995-04-04

Publications (1)

Publication Number Publication Date
AR002981A1 true AR002981A1 (es) 1998-05-27

Family

ID=13665401

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP960102037A AR002981A1 (es) 1995-04-04 1996-04-03 Un envase que aloja una composicion farmaceutica que comprende una solucion acuosa de clorhidrato de procaterol, y una composicion farmaceutica quecomprende una solucion acuosa de clorhidrato de procaterol

Country Status (7)

Country Link
EP (1) EP0820274A1 (es)
KR (1) KR19980703582A (es)
AR (1) AR002981A1 (es)
AU (1) AU5015296A (es)
CA (1) CA2217360A1 (es)
MX (1) MX9707695A (es)
WO (1) WO1996031195A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002058668A2 (en) * 2000-12-21 2002-08-01 Alcon, Inc Artificial tear composition adapted to be used with contact lenses
US9636355B2 (en) * 2011-09-22 2017-05-02 Theo Holdings, Llc Hypertonic dextran solution and methods of treating and preventing recurrent corneal erosion
AU2015257874B2 (en) * 2014-05-07 2019-11-28 Croma-Pharma Gesellschaft M.B.H. Aqueous ophthalmic solution and method for treating dry eye syndrome
KR102487614B1 (ko) * 2015-10-06 2023-01-12 에이치엘비테라퓨틱스 주식회사 티모신 β4를 포함하는 안약의 제조방법
RU2743274C9 (ru) * 2015-11-10 2021-04-08 Общество с ограниченной ответственностью "ДИАМЕД-фарма" Фармацевтический препарат для лечения артрологических заболеваний
RU2612019C1 (ru) * 2015-12-11 2017-03-01 Общество с ограниченной ответственностью "ДИАМЕД-фарма" Способ производства инъекционной формы препарата на основе хондроитина сульфата
CN114159398B (zh) * 2021-03-22 2023-05-23 南京艾德加生物制药科技有限公司 一种盐酸丙卡特罗口服固体组合物及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2638156B2 (ja) * 1988-11-11 1997-08-06 優樹 小田切 薬剤組成物
JP3390477B2 (ja) * 1993-01-25 2003-03-24 生化学工業株式会社 薬剤組成物及びその製造法

Also Published As

Publication number Publication date
WO1996031195A1 (en) 1996-10-10
MX9707695A (es) 1997-12-31
KR19980703582A (ko) 1998-11-05
CA2217360A1 (en) 1996-10-10
EP0820274A1 (en) 1998-01-28
AU5015296A (en) 1996-10-23

Similar Documents

Publication Publication Date Title
NZ504653A (en) Cosmetic compositions with dibenzylidene sorbitol and functionalized silicones
MX166631B (es) Mejoras a champu de ph bajo conteniendo climbazole
BR0014486A (pt) Composições farmacêuticas contendo polipeptìdeo lìquido estabilizado
ES2097546T3 (es) Preparaciones cosmeticas desodorantes que contienen esteres di- o trigliceridos.
PE84899A1 (es) Formulaciones farmaceuticas que contienen voriconazol
ATE87319T1 (de) Inklusionskomplexe von 7-isopropoxy-isoflavon mit cyclodextrinen, verfahren zu deren herstellung und diese inklusionskomplexe enthaltende pharmazeutische praeparate.
GR1001503B (el) Μέ?οδος δια την παρασκευή φαρμακευτικών ενώσεων αι οποίαι περιέχουν ως δραστική ουσία καρβονικά οξέα τα οποία περιέχουν ?είον κα?ώς και η χρησιμοποίησις αυτών δια την καταπολέμησιν των ρετροιών.
MXPA01012336A (es) Gel de silicon que contiene acido salicilico.
AR024634A1 (es) Composicion farmaceutica estabilizada en forma liofilizada
IL133614A0 (en) Medicinal compositions for application to mucosa
EA199900749A1 (ru) Фармацевтическая композиция
ES2194679T3 (es) Composiciones cosmeticas que contienen creatina, carnitina y/o acido piruvico.
ES2187428T3 (es) Composiciones que contienen agua mineral.
KR950032201A (ko) 프라노프로펜의 안정화 방법 및 안정한 프라노프로펜 액제
BR9809492A (pt) Composição farmacêutica aquosa injetável, e, processo para a preparação da mesma
BRPI0015939B8 (pt) sistema terapêutico transdérmico com estabilidade aperfeiçoada e processo para a sua preparação
BR9913135A (pt) Formulação oral
AR002981A1 (es) Un envase que aloja una composicion farmaceutica que comprende una solucion acuosa de clorhidrato de procaterol, y una composicion farmaceutica quecomprende una solucion acuosa de clorhidrato de procaterol
GT199800196A (es) Combinaciones de estatina-eter carboxialquilico.
KR950007857A (ko) 경구투여용 라파마이신 제제
NZ331083A (en) Pharmaceutical preparations of cilansetron stabilized against racemization
BR9816072A (pt) Composição clareadora da pele contendo um composto de ácido ascórbico
JPS57200361A (en) "indomethacin(r)" pharmaceutical with low irritant action
KR970073583A (ko) 탁속을 함유한 주사용 약제 조성물
HRP20020332B1 (en) Oral solution containing galanthamine and a sweetening agent